WallStreetZenWallStreetZen

NASDAQ: RLYB
Rallybio Corp Stock

$8.49+0.49 (+6.13%)
Updated Jun 5, 2023
RLYB Price
$8.49
Fair Value Price
N/A
Market Cap
$320.48M
52 Week Low
$4.15
52 Week High
$15.89
P/E
-4.16x
P/B
2.06x
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
$0.00
Earnings
-$69.47M
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
0.05
Operating Cash Flow
-$62M
Beta
1.15
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A

RLYB Overview

Rallybio Corporation is a clinical-stage biotechnology company offering programs for the prevention of Fetal and Neonatal Alloimmune Thrombocytopenia, a rare hematological disease that impacts fetuses and newborns. The company is also focused on developing therapies that address diseases of complement dysregulation, including Paroxysmal Nocturnal Hemoglobinuria, Generalized Myasthenia Gravis, and ophthalmic disorders. Rallybio Corporation was founded in 2018 and is headquartered in New Haven, CT.

Zen Score

Industry Average (26)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how RLYB scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

RLYB is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
RLYB is good value based on its book value relative to its share price (2.06x), compared to the US Biotechnology industry average (5.21x)
P/B vs Industry Valuation
RLYB is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 30 more RLYB due diligence checks available for Premium users.

Be the first to know about important RLYB news, forecast changes, insider trades & much more!

RLYB News

Valuation

RLYB price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-4.16x
Industry
11.59x
Market
53.21x

RLYB price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
2.06x
Industry
5.21x
RLYB is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

RLYB's financial health

Profit margin

Revenue
$0.0
Net Income
-$17.3M
Profit Margin
0%
RLYB's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials

Assets to liabilities

Assets
$162.3M
Liabilities
$7.1M
Debt to equity
0.05
RLYB's short-term assets ($161.28M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
RLYB's short-term assets ($161.28M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
RLYB's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$18.8M
Investing
$1.5M
Financing
-$139.0k
RLYB's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

RLYB vs Biotech Stocks

TickerMarket Cap1d %P/EP/B
RLYB$320.48M+6.13%-4.16x2.06x
DRTS$324.93M+2.17%-8.87x3.08x
SVRA$326.23M-1.38%-10.59x3.32x
MGNX$310.43M+3.29%-3.41x2.84x
DSGN$308.26M-4.34%-4.41x0.99x

Rallybio Stock FAQ

What is Rallybio's quote symbol?

(NASDAQ: RLYB) Rallybio trades on the NASDAQ under the ticker symbol RLYB. Rallybio stock quotes can also be displayed as NASDAQ: RLYB.

If you're new to stock investing, here's how to buy Rallybio stock.

What is the 52 week high and low for Rallybio (NASDAQ: RLYB)?

(NASDAQ: RLYB) Rallybio's 52-week high was $15.89, and its 52-week low was $4.15. It is currently -46.57% from its 52-week high and 104.58% from its 52-week low.

How much is Rallybio stock worth today?

(NASDAQ: RLYB) Rallybio currently has 37,747,433 outstanding shares. With Rallybio stock trading at $8.49 per share, the total value of Rallybio stock (market capitalization) is $320.48M.

Rallybio stock was originally listed at a price of $14.10 in Jul 29, 2021. If you had invested in Rallybio stock at $14.10, your return over the last 1 years would have been -39.79%, for an annualized return of -39.79% (not including any dividends or dividend reinvestments).

How much is Rallybio's stock price per share?

(NASDAQ: RLYB) Rallybio stock price per share is $8.49 today (as of Jun 5, 2023).

What is Rallybio's Market Cap?

(NASDAQ: RLYB) Rallybio's market cap is $320.48M, as of Jun 6, 2023.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Rallybio's market cap is calculated by multiplying RLYB's current stock price of $8.49 by RLYB's total outstanding shares of 37,747,433.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.